Tagged With Gilead Sciences

See the pitch deck a healthcare startup founded by 2 ex-Googlers used to raise $47 million

Immunomedics soars 106% after Gilead agrees to acquire the cancer-drug company for $21 billion

Dow gains 369 points on trader optimism around a COVID-19 treatment

US stocks fluctuate as traders weigh virus spike against advances in treatment

The US bought up 90% of the world's supply of remdesivir for the next 3 months, and patents mean many countries won't be able to get any

Pharmaceutical giants have added $51 billion to their market value in 2020 as they scramble to develop a coronavirus vaccine

Gilead rises after pricing its coronavirus-fighting drug remdesivir

EXCLUSIVE: See the presentation Cedar used to convince investors like Andreessen Horowitz to invest $102 million

The $96 billion biotech Gilead will start testing a new version of the first effective coronavirus treatment, and it could make remdesivir available to vastly more patients

The federal government finally announced initial plans to distribute Gilead's coronavirus drug remdesivir after days of confusion

Gilead has yet to set a price for the coronavirus treatment remdesivir, but an influential drug pricing watchdog says it could be worth up to $4,500 per patient

Dispensed: A week of drug developments, the plan to restart hospitals, and some non-coronavirus news

Scientists are racing to discover ways to treat and prevent coronavirus. Here's the difference between a treatment and a vaccine.

Gilead's coronavirus treatment remdesivir just succeeded in a crucial study, raising hopes for a first COVID-19 drug

Dispensed: Doctors are seeing new COVID-19 complications and symptoms, the promises and pitfalls of getting back to business, and why the healthcare industry will never be the same

WHO mistakenly posted study results that appeared to show that a leading potential coronavirus treatment failed to help patients

One Wall Street firm says approval for Gilead's experimental coronavirus treatment is a coin-flip bet at best — but still thinks you should buy the stock right now

Gilead just made a $4.9 billion bet on cancer-drug maker Forty Seven, whose stock skyrocketed 62%

Dispensed: Coronavirus spreads, drugmakers scramble to respond, and the latest magic mushroom startups

A small group of scientists, execs, and VCs are $277 million richer as their companies race to create a coronavirus vaccine. Here are 7 who have raked in huge sums.